- Home
- ALVR vs GNSS Comparison
ALVR vs GNSS Comparison
Compare ALVR & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- GNSS
- Stock Information
- Founded
- ALVR 2013
- GNSS 1992
- Country
- ALVR United States
- GNSS United States
- Employees
- ALVR N/A
- GNSS N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- GNSS Consumer Electronics/Appliances
- Sector
- ALVR Health Care
- GNSS Consumer Staples
- Exchange
- ALVR Nasdaq
- GNSS Nasdaq
- Market Cap
- ALVR 87.7M
- GNSS 169.5M
- IPO Year
- ALVR 2020
- GNSS N/A
- Fundamental
- Price
- ALVR $0.94
- GNSS $3.75
- Analyst Decision
- ALVR Sell
- GNSS Strong Buy
- Analyst Count
- ALVR 5
- GNSS 3
- Target Price
- ALVR $1.00
- GNSS $5.08
- AVG Volume (30 Days)
- ALVR 155.6K
- GNSS 106.7K
- Earning Date
- ALVR 11-04-2024
- GNSS 12-05-2024
- Dividend Yield
- ALVR N/A
- GNSS N/A
- EPS Growth
- ALVR N/A
- GNSS N/A
- EPS
- ALVR N/A
- GNSS N/A
- Revenue
- ALVR N/A
- GNSS $27,968,000.00
- Revenue This Year
- ALVR N/A
- GNSS N/A
- Revenue Next Year
- ALVR N/A
- GNSS $138.10
- P/E Ratio
- ALVR N/A
- GNSS N/A
- Revenue Growth
- ALVR N/A
- GNSS N/A
- 52 Week Low
- ALVR $0.58
- GNSS $1.51
- 52 Week High
- ALVR $2.49
- GNSS $4.04
- Technical
- Relative Strength Index (RSI)
- ALVR 69.10
- GNSS 60.29
- Support Level
- ALVR $0.74
- GNSS $3.67
- Resistance Level
- ALVR $0.91
- GNSS $3.94
- Average True Range (ATR)
- ALVR 0.06
- GNSS 0.14
- MACD
- ALVR 0.01
- GNSS -0.02
- Stochastic Oscillator
- ALVR 94.50
- GNSS 77.78
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About GNSS Genasys Inc.
Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.